<DOC>
	<DOCNO>NCT00609596</DOCNO>
	<brief_summary>Dutasteride tamsulosin treat benign prostatic hyperplasia . Studies show give together , improvement symptom either drug alone . In study , look see 2 different formulation tamsulosin combination capsule 7 day dose US commercial tamsulosin dutasteride .</brief_summary>
	<brief_title>A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State .</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Inclusion criterion : Healthy determine responsible physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure . Subjects orthostasis screen excluded enrollment . Males 18 45 year age ( inclusive ) . Male subject must agree use one contraception method . This criterion must follow time first dose study medication followup study . Body weight &lt; / 55 kg BMI within range 19.0 30.0 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form . QTcB QTcF &lt; 450 msec . Subjects must agree donate blood blood product 6 month last dose study medication . Exclusion criterion : The subject positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . Slow metabolizer CYP2D6 determine screen PGx analysis . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : An average weekly intake &gt; 14 drinks/week . One drink equivalent : 12 g alcohol = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication collection final PK sample study , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . History sensitivity study medication , component thereof , include sulfonamide , history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . History postural hypotension , dizziness , poor hydration , vertigo , vasovagal reaction sign symptom orthostasis , opinion investigator could exacerbate tamsulosin result put subject risk injury . Orthostatic hypotension screening , define reduction systolic blood pressure 20 mmHg and/or reduction diastolic blood pressure 10 mmHg stand vs. supine measurement . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Unwillingness inability follow procedure outline protocol . History sensitivity heparin heparininduced thrombocytopenia . Consumption red wine , seville orange , grapefruit , grapefruit juice cruciferous vegetable ( watercress , broccoli , cabbage , Brussels sprout ) 7 day prior first dose study medication collection final PK sample study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>dutasteride</keyword>
	<keyword>tamsulosin</keyword>
	<keyword>benign prostatic hyperplasia</keyword>
</DOC>